Valuation (67%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 14.14 | N/A |
| PEG Ratio (TTM) | 4.24 | N/A |
| P/S Ratio (TTM) | 2.34 | N/A |
| P/B Ratio (TTM) | 1.57 | N/A |
| P/FCF Ratio (TTM) | 15.44 | N/A |
| Price to 5YR AVG Earnings Ratio | 16.52 | N/A |
| Price to 5YR AVG FCF Ratio | 12.35 | N/A |
Profitability (35%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.83% | N/A |
| ROE (TTM) | 12.05% | N/A |
| Net Profit Margin (TTM) | 16.58% | N/A |
| ROIC 5YR AVG | -37.27% | N/A |
Growth (83%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 7.16% | 22.70% | 14.22% |
| Revenue | 14.81% | 8.39% | 88.24% |
| Net Income | 7.26% | 21.81% | 13.76% |
| Cash Flow | 3.21% | 22.43% | 14.56% |
Health (77%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 35.61 | N/A |
| Quick Ratio (TTM) | 35.61 | N/A |
| D/E Ratio (TTM) | 0.18 | N/A |
| Interest Coverage (TTM) | 0.50 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 0.55 | N/A |
| LTL to 5YR AVG FCF | 0.85 | N/A |
| Shares Outstanding Growth 5YR AVG | -0.34% | N/A |